WhatDoTheyPrescribe.com is an educational resource explaining real-world prescribing patterns and is not a substitute for professional medical advice.

What do they prescribe?

Specify State (optional)

Search by Prescriber

Search by Drug

Doctors Who Prescribe Empagliflozin (Jardiance, Glyxambi, Synjardy, Trijardy) in Florida

Also known as: Jardiance, Glyxambi, Synjardy, Trijardy

Find doctors, physicians, and healthcare providers who prescribe Empagliflozin in Florida. This page lists the top prescribers of Empagliflozin based on Medicare Part D data, including the number of claims, patients served, and total drug costs.

What is Empagliflozin?

SYNJARDY SYNJARDY is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin hydrochloride (HCl) immediate-release, a biguanide, indicated as an additional treatment to diet and exercise to improve glycemic control in adults and children aged 10 years and older with type 2 diabetes. It belongs to a class of drugs known as sodium-glucose cotransporter 2 inhibitor.

Total Claims in Florida
421,047
5.6% of all Empagliflozin prescriptions nationwide
Total Beneficiaries in Florida
89,204
Total Cost in Florida
$483,809,427

Top Prescribers in FL(7+)

Specify State (optional)

PrescriberLocationTypeClaimsBeneficiariesCost
Eugenio Angueira-SerranoMiami, FLEndocrinology2,175527$1,996,070
Mauricio MelhadoWest Palm Beach, FLCardiology1,562374$1,341,383
Annapoorna ArunachalamPalm Springs, FLEndocrinology891214$718,397
Gian-Carlo GioveTallahassee, FLAdvanced Heart Failure and Transplant Cardiology851212$638,601
Kenneth ShephardMiami, FLInternal Medicine736184$650,834
Carlos BarreraMiami, FLPulmonary Disease722138$564,417
Janet MartinezMiami, FLNurse Practitioner720209$578,619
Loading more data in background...

Find Empagliflozin doctors in other states

AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services.
Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.